Catalyst Wire Dossier Catalyst Wire Dossier

Risarg

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Risarg, covering 2025-12-05 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

See pricing